Healthcare

AI prescribing receives state-supervised test in Utah

Utah approved a supervised pilot allowing Nolla Health’s AI-powered dermatology app to issue initial prescriptions for certain acne medicines.

Nolla Health announced that Utah had approved a state-supervised pilot allowing its Nolla Derm application to issue initial prescriptions for certain acne medicines. The program began on October 5, 2026, and was described as one of the most significant experiments in AI-led healthcare. The application is intended to automate part of the prescribing process for a defined dermatology use case. The development matters because prescribing has traditionally required clinician involvement, and regulatory approval for an AI system to issue initial prescriptions creates a test of how such systems can operate under government supervision. The available report does not specify the exact medicines, eligibility rules, safety monitoring procedures, or clinical outcomes. It also does not establish that the model can prescribe beyond the approved pilot’s scope.

Original source: Chief Healthcare Executive

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI